Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices and laboratory equipment worldwide. The company operates in two segments, Laboratory and Scientific Products, and Medical Devices. The Laboratory and Scientific Products segment offers Sonicator ultrasonic liquid processors; Aura ductless fume enclosures for filtration of gaseous contaminates; Labcaire autoscope and Guardian endoscope disinfectant systems, which controls and eliminates hazardous vapors, noxious odors, and particulates in the laboratory; and Jet AER autoscope, a reprocessing, disinfecting, and rinsing equipment. The Medical Devices segment provides Auto Sonix ultrasonic cutting and coagulatory system, ultrasound systems, replacement transducers, ultrasonic lithotriptor, ultrasonic neuroaspirator used for neurosurgery, and soft tissue aspirator used primarily for the cosmetic surgery market. It also offers ISIS systems for the protection of personnel, products, and the environment from airborne hazards; and Sonablate 500 for the ablation of cancerous tissue in the prostate. The company primarily serves medical, pharmaceutical, semiconductor, biotechnology, and forensic industries. Its customers include end users, such as doctors, hospitals, and distributors. The company markets its products through direct salespersons, distributors, manufacturing representatives, and catalog listings. Misonix was founded in 1959 and is based in Farmingdale, New York.